Terns Pharmaceuticals (TERN) Competitors $6.05 +0.29 (+5.03%) (As of 12/19/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends TERN vs. LBPH, NAMS, IDYA, RXRX, CNTA, APGE, IBRX, WVE, MIRM, and AKROShould you be buying Terns Pharmaceuticals stock or one of its competitors? The main competitors of Terns Pharmaceuticals include Longboard Pharmaceuticals (LBPH), NewAmsterdam Pharma (NAMS), IDEAYA Biosciences (IDYA), Recursion Pharmaceuticals (RXRX), Centessa Pharmaceuticals (CNTA), Apogee Therapeutics (APGE), ImmunityBio (IBRX), Wave Life Sciences (WVE), Mirum Pharmaceuticals (MIRM), and Akero Therapeutics (AKRO). These companies are all part of the "pharmaceutical products" industry. Terns Pharmaceuticals vs. Longboard Pharmaceuticals NewAmsterdam Pharma IDEAYA Biosciences Recursion Pharmaceuticals Centessa Pharmaceuticals Apogee Therapeutics ImmunityBio Wave Life Sciences Mirum Pharmaceuticals Akero Therapeutics Terns Pharmaceuticals (NASDAQ:TERN) and Longboard Pharmaceuticals (NASDAQ:LBPH) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, community ranking, valuation, risk, institutional ownership and earnings. Do analysts rate TERN or LBPH? Terns Pharmaceuticals currently has a consensus target price of $18.30, suggesting a potential upside of 202.48%. Longboard Pharmaceuticals has a consensus target price of $59.56, suggesting a potential downside of 0.71%. Given Terns Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Terns Pharmaceuticals is more favorable than Longboard Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Terns Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Longboard Pharmaceuticals 0 Sell rating(s) 5 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.44 Which has higher earnings and valuation, TERN or LBPH? Longboard Pharmaceuticals has lower revenue, but higher earnings than Terns Pharmaceuticals. Longboard Pharmaceuticals is trading at a lower price-to-earnings ratio than Terns Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTerns Pharmaceuticals$1M513.88-$90.21M-$1.18-5.13Longboard PharmaceuticalsN/AN/A-$54.42M-$2.23-26.90 Does the MarketBeat Community believe in TERN or LBPH? Longboard Pharmaceuticals received 21 more outperform votes than Terns Pharmaceuticals when rated by MarketBeat users. Likewise, 75.00% of users gave Longboard Pharmaceuticals an outperform vote while only 60.87% of users gave Terns Pharmaceuticals an outperform vote. CompanyUnderperformOutperformTerns PharmaceuticalsOutperform Votes4260.87% Underperform Votes2739.13% Longboard PharmaceuticalsOutperform Votes6375.00% Underperform Votes2125.00% Which has more volatility and risk, TERN or LBPH? Terns Pharmaceuticals has a beta of -0.36, meaning that its stock price is 136% less volatile than the S&P 500. Comparatively, Longboard Pharmaceuticals has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500. Do institutionals and insiders believe in TERN or LBPH? 98.3% of Terns Pharmaceuticals shares are held by institutional investors. Comparatively, 63.3% of Longboard Pharmaceuticals shares are held by institutional investors. 15.1% of Terns Pharmaceuticals shares are held by insiders. Comparatively, 4.6% of Longboard Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media favor TERN or LBPH? In the previous week, Longboard Pharmaceuticals had 1 more articles in the media than Terns Pharmaceuticals. MarketBeat recorded 3 mentions for Longboard Pharmaceuticals and 2 mentions for Terns Pharmaceuticals. Terns Pharmaceuticals' average media sentiment score of 0.97 beat Longboard Pharmaceuticals' score of 0.00 indicating that Terns Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Terns Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Longboard Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is TERN or LBPH more profitable? Terns Pharmaceuticals' return on equity of -32.76% beat Longboard Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Terns PharmaceuticalsN/A -32.76% -31.33% Longboard Pharmaceuticals N/A -33.03%-30.90% SummaryTerns Pharmaceuticals beats Longboard Pharmaceuticals on 9 of the 15 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.>> Register for the Workshop Now Get Terns Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TERN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TERN vs. The Competition Export to ExcelMetricTerns PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$513.88M$6.65B$5.00B$8.98BDividend YieldN/A3.08%4.87%4.13%P/E Ratio-5.1310.44135.2517.00Price / Sales513.88194.041,131.29115.43Price / CashN/A57.1640.5538.38Price / Book1.465.104.724.70Net Income-$90.21M$151.77M$118.55M$225.32M7 Day Performance-10.10%-2.45%-2.51%-2.34%1 Month Performance8.04%-3.71%11.34%2.94%1 Year Performance-3.82%12.27%30.31%16.90% Terns Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TERNTerns Pharmaceuticals4.1817 of 5 stars$6.05+5.0%$18.30+202.5%-6.1%$513.88M$1M-5.1340High Trading VolumeLBPHLongboard Pharmaceuticals0.6887 of 5 stars$59.98+0.0%$59.56-0.7%+963.5%$2.34BN/A-26.9020NAMSNewAmsterdam Pharma2.8184 of 5 stars$24.50-0.8%$36.20+47.8%+137.3%$2.26B$33.59M0.0057Analyst RevisionGap DownIDYAIDEAYA Biosciences4.2909 of 5 stars$25.86+2.7%$53.67+107.5%-28.0%$2.24B$3.92M-10.8180Analyst ForecastRXRXRecursion Pharmaceuticals2.4195 of 5 stars$7.51+8.1%$9.25+23.2%-39.3%$2.15B$44.58M-4.85400Gap UpHigh Trading VolumeCNTACentessa Pharmaceuticals3 of 5 stars$16.29-1.7%$25.83+58.6%+127.9%$2.15B$6.85M-10.8372Insider TradeAPGEApogee Therapeutics2.6219 of 5 stars$46.76+5.1%$83.88+79.4%+102.5%$2.11BN/A-18.3991IBRXImmunityBio2.156 of 5 stars$3.01+4.9%$17.38+477.2%-37.3%$2.10B$7.33M-3.36590Gap UpWVEWave Life Sciences4.889 of 5 stars$13.57+1.0%$22.22+63.8%+165.4%$2.07B$113.31M-12.11240Positive NewsMIRMMirum Pharmaceuticals4.069 of 5 stars$42.51+0.2%$57.73+35.8%+30.3%$2.04B$307.03M-21.01140Positive NewsAKROAkero Therapeutics3.9056 of 5 stars$29.00+0.4%$46.83+61.5%+23.0%$2.02BN/A-7.7030Insider Trade Related Companies and Tools Related Companies Longboard Pharmaceuticals Competitors NewAmsterdam Pharma Competitors IDEAYA Biosciences Competitors Recursion Pharmaceuticals Competitors Centessa Pharmaceuticals Competitors Apogee Therapeutics Competitors ImmunityBio Competitors Wave Life Sciences Competitors Mirum Pharmaceuticals Competitors Akero Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TERN) was last updated on 12/20/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBitcoin is going to $100,000 … before Inauguration DayMark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsored“Energy’s holy grail” just discoveredIt’s 17,000 times more powerful than gas… 2.75 million times more powerful than coal… and a staggering… 3 mill...Banyan Hill Publishing | Sponsored 5 military stocks to invest in If you’re a person of action, you can get in on a new US superweapon so savage it dwarfs the atomic bomb. Spec...Paradigm Press | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored2025’s #1 Trump TradeAll the Energy You Need to Power Your Entire Life... Could Fit Inside This Single Soda Can. Three Companies...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terns Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Terns Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.